Evidence-based·Updated November 20, 2026·How we grade evidence

Mirtazapine

MedicationAntidepressant (prescription)

Mirtazapine is an established antidepressant. A network meta-analysis of 522 trials found all 21 antidepressants studied, including mirtazapine, more effective than placebo for adult depression, and mirtazapine was among those that did better in head-to-head trials. A Cochrane review found it worked faster than SSRIs at 2 weeks but caused more weight gain and sleepiness. Alcohol, St. John's wort and tryptophan are the high-severity interactions: alcohol adds to drowsiness and impaired coordination, and the two supplements raise serotonin syndrome risk.

Taking Mirtazapine with other supplements or medications?Check your whole list for interactions. Free, no account.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults with major depressive disorder whose prescriber recommends mirtazapine, for example when sleep problems or poor appetite are part of the picture

Common dosing range

Set by your prescriber. The Remeron label starts at 15 mg once daily, preferably in the evening before sleep, with increases up to a maximum of 45 mg a day, no more often than every 1 to 2 weeks

When to expect effects

Label trials lasted 6 weeks; the Cochrane review found more responders than with SSRIs already at 2 weeks

Watch out for

Boxed warning for suicidal thoughts and behaviors in children, teens and young adults. Avoid alcohol and benzodiazepines. Never combine with MAO inhibitors. Rarely causes agranulocytosis: report fever, sore throat or mouth sores. Do not stop suddenly

What is it

Mirtazapine is a prescription antidepressant with a tetracyclic structure, sold as generic tablets, Remeron film-coated tablets (15 mg and 30 mg) and RemeronSolTab orally disintegrating tablets (15, 30 and 45 mg). The Remeron label approves it for major depressive disorder in adults only; it is not approved for children. It is known for causing sleepiness and increased appetite with weight gain. Its boxed warning covers suicidal thoughts and behaviors in young people. For supplements and drinks, alcohol is the high-severity interaction on this page and saffron a low-severity one.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have major depressive disorder and your prescriber recommends mirtazapine (with a prescriber)
You and your prescriber prefer an antidepressant that is taken at bedtime and is less likely than SSRIs to cause nausea or sexual side effects, accepting more sleepiness and weight gain (with a prescriber)
You can avoid alcohol and keep follow-up visits, especially in the first months and after dose changes

Probably skip if…

You take an MAO inhibitor or stopped one in the last 14 days, including linezolid or intravenous methylene blue (contraindicated)
You have had a serious skin or allergic reaction to mirtazapine (contraindicated)
You plan to keep drinking alcohol regularly or take benzodiazepines without your prescriber's advice
You are under 18: mirtazapine is not approved for children, and data from two pediatric trials were insufficient to establish safety and effectiveness
You have phenylketonuria and are offered RemeronSolTab, which contains phenylalanine, without your prescriber knowing

Evidence at a glance

major depressive disorder in adults

Good Evidence
Effect
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Best fit
Adults with major depressive disorder, without bipolar or psychotic features
Time
Acute treatment trials lasting weeks

speed of response compared with other antidepressants

Limited Evidence
Effect
Small to moderate; odds of response 1.57 times SSRIs at 2 weeks and 1.19 times at 6 to 12 weeks
Best fit
Adults with major depression for whom a faster early response matters and weight gain is acceptable
Time
Differences seen from 2 weeks

Evidence for 2 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

major depressive disorder in adults

Disease adjunct
Good Evidence

A 2018 network meta-analysis of 522 double-blind trials with 116,477 adults found that all 21 antidepressants studied, including mirtazapine, were more effective than placebo for acute treatment of major depression, with odds ratios from 1.37 to 2.13. In head-to-head trials, mirtazapine was among the drugs that were more effective than other antidepressants (odds ratios 1.19 to 1.96 for that group). The authors rated the certainty of evidence moderate to very low. Trials with many people with bipolar, psychotic or treatment-resistant depression were excluded.

Effect size
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Time to effect
Acute treatment trials lasting weeks
Best fit
Adults with major depressive disorder, without bipolar or psychotic features
Less likely
Children and teens, and people with bipolar or psychotic depression, who were excluded

Bottom line: Mirtazapine works better than placebo for adult depression and did well in head-to-head comparisons.

speed of response compared with other antidepressants

Disease adjunct
Limited Evidence

A 2011 Cochrane review of 29 randomized trials (4,974 adults), mostly 6-week outpatient studies with poorly reported risk of bias, compared mirtazapine with other antidepressants. Against SSRIs, mirtazapine gave more responders at 2 weeks (odds ratio 1.57) and at the end of acute treatment (odds ratio 1.19). Against tricyclic antidepressants there was no clear difference. Dropout rates were similar, but mirtazapine caused more weight gain, increased appetite and sleepiness than SSRIs, and less nausea, vomiting and sexual dysfunction.

Effect size
Small to moderate; odds of response 1.57 times SSRIs at 2 weeks and 1.19 times at 6 to 12 weeks
Time to effect
Differences seen from 2 weeks
Best fit
Adults with major depression for whom a faster early response matters and weight gain is acceptable
Less likely
People for whom weight gain or daytime sleepiness would be a serious problem

Bottom line: Mirtazapine may work somewhat faster than SSRIs, with a different side-effect profile: more weight gain and sleepiness, less nausea and sexual dysfunction.

How it works

The Remeron label says the way mirtazapine works in depression is unclear, but it blocks alpha-2 receptors in the brain, which is thought to increase the release of norepinephrine and serotonin. It also blocks serotonin 5-HT2 and 5-HT3 receptors and, strongly, histamine H1 receptors; the label links the H1 effect to its sleepiness and its alpha-1 blocking to dizziness on standing. The label gives a half-life of about 20 to 40 hours, longer on average in women (37 hours) than in men (26 hours), with steady levels in about 5 days. These features shape its interactions. Alcohol and benzodiazepines add to mirtazapine's impairment of thinking and coordination. Because it raises serotonergic activity, the label lists serotonin syndrome risk with other serotonergic products, including St. John's wort and tryptophan, and MAO inhibitors are contraindicated. It is cleared by the liver enzymes CYP2D6, CYP1A2 and CYP3A, so strong CYP3A inducers such as carbamazepine lower its levels and strong CYP3A inhibitors raise them.

How to take it

1. Typical dose
Your prescriber sets the dose. The Remeron label starts at 15 mg once daily. If response is not enough, the dose can be raised up to a maximum of 45 mg a day, with changes no more often than every 1 to 2 weeks. Before starting, the label calls for screening for a personal or family history of bipolar disorder, mania or hypomania. Lower doses may be needed with moderate to severe kidney or liver impairment, and in older adults, whose clearance is lower.
2. Higher studied dose
The label maximum is 45 mg a day. In the label's 6-week trials the mean dose among those who completed them was 21 to 32 mg a day.
3. Timing
Once daily, preferably in the evening before sleep, as the label directs
4. With food
The label says food has a minimal effect on absorption.
5. Split dosing
Not split; once daily. RemeronSolTab should not be split: it is placed whole on the tongue right after opening the blister and dissolves in saliva
6. How long to try
Your prescriber decides how long. In a label trial, people who kept taking mirtazapine after responding had fewer relapses over 40 weeks than those switched to placebo. When stopping, the label recommends a gradual dose reduction rather than abrupt stopping whenever possible. At least 14 days must pass between stopping an MAO inhibitor and starting mirtazapine, and the reverse.

What to track

New or worse depression, anxiety, agitation, unusual behavior or suicidal thoughts, especially in the first months and after dose changes (contact your provider right away)
Fever, sore throat, mouth sores or other signs of infection (contact your prescriber; a blood count may be needed)
Daytime sleepiness and how it affects driving or work, especially early on
Appetite and weight, and cholesterol and triglycerides if your prescriber checks them
Agitation, sweating, fast heartbeat, tremor or fever, which can signal serotonin syndrome (seek urgent care)
Dizziness, abnormal dreams, electric-shock sensations or nausea after a missed dose or dose reduction

Bottom line: Your prescriber sets the dose; take it once in the evening, avoid alcohol, and do not stop suddenly on your own.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Sleepiness (54% versus 18% on placebo in 6-week label trials)Increased appetite (17%) and weight gain (12%)Dry mouth (25%) and constipation (13%)Dizziness (7%) and weaknessHigher cholesterol and triglycerides in some people

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the Remeron label says long experience in pregnant women, from published observational studies and postmarketing reports, has not reliably identified a drug-associated risk of major birth defects, miscarriage or other harmful outcomes. Women who stop antidepressants during pregnancy are more likely to relapse, so the risks of untreated depression also count. A national pregnancy registry for antidepressants collects outcomes. Breastfeeding: mirtazapine passes into breast milk at low levels, with relative infant doses of 0.6% to 2.8% of the mother's weight-adjusted dose, and no adverse effects were reported in most breastfed infants. The label says to weigh the benefits of breastfeeding against the mother's need for mirtazapine and any possible effects on the infant.

Interactions

MAO inhibitors (such as phenelzine, tranylcypromine, isocarboxazid, selegiline, linezolid, intravenous methylene blue)Critical

Contraindicated because of the risk of serotonin syndrome. The label requires at least 14 days between stopping an MAOI and starting mirtazapine, and at least 14 days after stopping mirtazapine before starting an MAOI.

AlcoholHigh

The Remeron label says alcohol adds to the impairment of thinking and motor skills that mirtazapine causes on its own, and that alcohol should be avoided during treatment. In a small label study, alcohol barely changed mirtazapine blood levels, so the risk is the added effect, not a higher drug level. Avoid alcohol while taking mirtazapine, do not drive if you feel drowsy, and discuss your drinking with your prescriber or pharmacist.

Other serotonergic medicines (SSRIs, SNRIs, triptans, tricyclic antidepressants, tramadol, fentanyl, lithium, buspirone, amphetamines)High

The label says combining serotonergic drugs with mirtazapine increases the risk of serotonin syndrome and calls for monitoring, especially when starting or raising a dose. Seek urgent care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.

Benzodiazepines (such as diazepam, alprazolam)High

The label says benzodiazepines add to mirtazapine's impairment of thinking and motor skills and that the combination should be avoided. Talk to your prescriber if you take one for anxiety or sleep.

St. John's wort (Hypericum perforatum)High

The label lists St. John's Wort among serotonergic products that raise the risk of serotonin syndrome with mirtazapine, particularly when treatment starts or the dose goes up. No published case with this exact pair was found, and a change in mirtazapine levels from the herb has not been shown. Do not add it unless your prescriber advises it, and seek urgent care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.

L-tryptophan (supplements)High

The label lists tryptophan among serotonergic products that raise the risk of serotonin syndrome with mirtazapine, particularly when treatment starts or the dose goes up. No published case with this exact pair was found; the warning rests on the label and the shared effect on serotonin. Do not add a tryptophan supplement unless your prescriber advises it.

Saffron (supplements)Low

A 2023 systematic review of laboratory, animal and human research lists blocking the reuptake of dopamine, norepinephrine and serotonin among saffron's proposed mechanisms, which raises a theoretical concern about added serotonin effects. No trial has tested saffron with mirtazapine. In a placebo-controlled trial in 160 adults already taking an antidepressant, a standardized saffron extract (14 mg twice daily) for 8 weeks improved clinician-rated depression scores, but not self-rated scores, without increasing antidepressant side effects; its abstract does not name the antidepressants taken. The only trial that names them, a 4-week pilot in 40 adults, added crocin, a saffron compound, to the SSRIs fluoxetine, sertraline or citalopram. Discuss it with your prescriber before adding saffron.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

See all 3 Mirtazapine interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Generic mirtazapine, Remeron tablets (15 mg and 30 mg, scored) or RemeronSolTab orally disintegrating tablets (15, 30 and 45 mg), dispensed on your own prescription
A Medication Guide with each fill, which explains the suicidality warning
RemeronSolTab contains aspartame (phenylalanine), which matters for people with phenylketonuria
Once-daily evening dosing

Be skeptical of…

Mood or sleep supplements containing St. John's wort or tryptophan, which the label lists as serotonergic products that raise serotonin syndrome risk
Products sold as a natural replacement for mirtazapine, or advice to switch to herbs and stop the medicine
Online sellers offering mirtazapine without a prescription, including for sleep or weight gain
Advice to stop suddenly or skip doses to reduce side effects

Frequently asked questions

Can I drink alcohol while taking mirtazapine?⌄

The Remeron label says to avoid alcohol. Alcohol adds to the drowsiness and impaired coordination and judgment that mirtazapine causes, and this page rates the pair high. If you drink, talk to your prescriber or pharmacist, and do not drive if you feel drowsy.

Can I take saffron supplements with mirtazapine?⌄

The concern is theoretical. A review lists blocking serotonin reuptake among saffron's proposed mechanisms, but no trial has tested it with mirtazapine. One trial added a saffron extract to unnamed antidepressants and found antidepressant side effects did not get worse; a small pilot added a saffron compound, crocin, to the SSRIs fluoxetine, sertraline or citalopram, and its abstract does not report side-effect results. This page rates the pair low severity. Ask your prescriber before starting it.

Is it safe to take St. John's wort or tryptophan with mirtazapine?⌄

Ask your prescriber first. The Remeron label lists St. John's wort and tryptophan among serotonergic products that raise the risk of serotonin syndrome when combined with mirtazapine.

Why does mirtazapine make me sleepy and hungry?⌄

The label links its sleepiness to strong blocking of histamine H1 receptors. In 6-week trials, 54% of people reported sleepiness and 17% increased appetite, and 12% reported weight gain. The label advises caution with driving until you know how it affects you.

What happens if I stop mirtazapine suddenly?⌄

Stopping, especially abruptly, can cause dizziness, abnormal dreams, electric-shock sensations, agitation, anxiety, nausea and sweating. The label recommends a gradual reduction. Talk to your prescriber before making any change.

References by claim

major depressive disorder in adults

Cipriani et al., 2018 · PMC (2018) link

speed of response compared with other antidepressants

Watanabe et al., 2011 · PMC (2011) link

Safety

Remeron and RemeronSolTab (mirtazapine) prescribing information · DailyMed (FDA label) link

Interaction: Saffron (supplements)

Lopresti et al., 2019 · PubMed (2019) link

Talaei et al., 2015 · PubMed (2015) link

Matraszek-Gawron et al., 2022 · PMC (2022) link

Track Mirtazapine with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.